SOLTA MEDICAL INC

Q: Sep 30 2013

Q: Sep 30 2013

Q: Jun 30 2013

Q: Mar 31 2013

FY: Dec 31 2012

Q: Sep 30 2012

Q: Jun 30 2012

Q: Jun 30 2012

Q: Mar 31 2012

FY: Dec 31 2011

Q: Sep 30 2011

Q: Jun 30 2011

Q: Mar 31 2011

FY: Dec 31 2010

FY: Dec 31 2010

Q: Sep 30 2010

Q: Jun 30 2010

Q: Mar 31 2010

FY: Dec 31 2009

Q: Sep 30 2009

1.02,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01

1.01,8.01,9.01

5.02

1.01,2.03

1.01,2.03

1.01,2.02,2.03,2.05,7.01,9.01

1.01,2.03,9.01

5.02

2.02,5.02,9.01

5.07

5.02,9.01

2.02,9.01

1.01,2.03,9.01

2.01,5.02,9.01

2.02,9.01

5.02

1.01,2.02,3.02,9.01

5.02

2.02,9.01

Entry into a Material Definitive Agreement

Certification of termination of registration of a class of securities (Section 12(b))

Notice of Effectiveness

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notification of removal from listing and/or registration on a national securities exchange

Post Effective Amendment to S-8

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

06

No description available

Registration statement under Securities Act of 1933

Prospectus Supplement for Delayed or Continuous Offering

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Broadfin Capital, LLC

MERITECH CAPITAL PARTNERS II LP

none

none

STANG ERIC B

Ku Mingo

COVERT HAROLD L

Graebner Linda

Holthe David

McCarthy Cathy L

SIECZKAREK MARK M

GLENN JOHN

Ferrari H Daniel

Heigel Douglas W

Nardoci Jeffrey C

Parr Lisa D

Valeant Pharmaceuticals International, Inc.

SOLTA MEDICAL INC

none

none

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Annual Report Scanned (Paper)